Yes – as of June 2026, DEA-registered telehealth providers can legally prescribe Adderall, Vyvanse, and other Schedule II ADHD stimulants without a prior in-person visit, under temporary federal flexibilities that run through December 31, 2026. That permission is temporary rather than permanent: it rests on a federal extension that expires at the end of 2026, with the replacement rule still unfinished. And the federal rule is only the floor – your state’s law and your platform’s own policy can each be stricter, and either one can be the reason a specific service declines to prescribe a stimulant to you.
Where the rules stand right now: Telehealth prescribing of Schedule II-V controlled substances, including ADHD stimulants, is permitted nationwide under a temporary DEA/HHS extension that runs through December 31, 2026. A permanent replacement rule was proposed in January 2025 but has not been finalized. State laws and individual platform policies can both be stricter than the federal floor. Regulatory status last verified: June 12, 2026.
The three layers of rules – federal, state, platform
Most outdated articles on this topic stop at the federal rule. In practice, whether an online psychiatrist can prescribe Adderall to you depends on three separate layers, and you need a yes at every one of them.
Layer 1: Federal law – the Ryan Haight Act and its temporary waiver
The Ryan Haight Act of 2008 normally requires at least one in-person medical evaluation before a clinician can prescribe any controlled substance. That requirement was waived in March 2020 as part of the COVID-19 public health emergency, and the DEA and HHS have repeatedly extended the waiver since. The current authority is the fourth temporary extension, published in the Federal Register on December 31, 2025 (document 2025-24123), which covers Schedule II through Schedule V controlled substances through December 31, 2026. The DEA’s announcement framed the extension as preserving continuity of care while the agency finishes a permanent framework. The plain-English version: as of June 2026, telehealth prescribing of Schedule II ADHD stimulants is legal nationwide under a temporary DEA rule that expires December 31, 2026.
Layer 2: State law – the floor can be raised
Federal flexibility does not override state law, and states are free to impose stricter conditions on controlled-substance teleprescribing. New Jersey, for example, requires an in-person follow-up visit every three months for patients receiving Schedule II medications, which means a fully remote arrangement does not satisfy New Jersey law on its own. Florida went the other direction: in 2022 it amended section 456.47 of its statutes to explicitly permit Schedule II teleprescribing for psychiatric disorders. As of June 2026, the practical takeaway is that two patients using the same national platform can face different rules depending on which state they live in, so check your own state’s telehealth prescribing law alongside any platform’s policy.
Layer 3: Platform policy – often the strictest layer
Even where federal and state law both allow it, many telehealth companies restrict controlled substances further as a matter of internal policy and risk management. Circle Medical, for instance, excludes controlled-substance prescribing for residents of Georgia, Ohio, Michigan, and North Carolina. Talkspace prescribes no controlled substances at all, in any state. General-purpose telehealth services such as Teladoc and MDLIVE also exclude controlled substances entirely. None of these policies are required by federal law – they are business decisions, and they are the layer most likely to surprise patients who only read about the DEA rules.
Which online ADHD platforms actually prescribe stimulants?
The table below reflects each platform’s published prescribing policy, state coverage, and payment model as of June 2026. Our comparison is based on documented policies, pricing pages, and regulatory records – not on testing claims or platform marketing.
| Platform | Prescribes Adderall and other stimulants? | Key restrictions (June 2026) | Payment model |
|---|---|---|---|
| Talkiatry | Yes | Availability varies by state | Insurance only |
| Circle Medical | Yes | No controlled substances for GA, OH, MI, NC residents | PPO insurance or cash |
| ADHD Online (Mentavi) | Yes | Roughly 40 states; not available in ND or SC | Cash pay |
| Klarity Health | Provider-dependent | Marketplace model; each clinician sets policy | Cash pay |
| LifeStance | Yes | Hybrid model: in-person and telehealth | Insurance |
| Talkspace | No | Non-stimulant ADHD medications only | Insurance and cash |
- Talkiatry prescribes stimulants when clinically appropriate, but it is insurance-only and availability depends on your state.
- Circle Medical prescribes stimulants in most states, with a hard exclusion for Georgia, Ohio, Michigan, and North Carolina residents.
- ADHD Online (Mentavi) offers cash-pay evaluations and treatment in roughly 40 states, but not North Dakota or South Carolina.
- Klarity Health is a marketplace, so prescribing policy varies by the individual clinician you book rather than a single company rule.
- LifeStance combines in-person clinics with telehealth, which can simplify compliance in states that require periodic in-person visits.
- Talkspace does not prescribe any controlled substances; its psychiatry service handles non-stimulant ADHD treatment only.
What changes after December 31, 2026?
Honestly: nobody knows yet, including the platforms. On January 15, 2025, the DEA published a proposed rule titled “Special Registrations for Telemedicine,” which would create three tiers of telehealth prescribing registration and contemplates additional restrictions specifically for Schedule II drugs like Adderall. As of June 2026, that rule has still not been finalized, though the DEA has said it intends to finalize it before the current flexibilities expire at the end of 2026.
The provisions under discussion that would most affect ADHD patients include mandatory prescription drug monitoring program (PDMP) checks before prescribing, audio-video visit requirements rather than audio-only, and possible in-person visit requirements for Schedule II medications. Any of those could change how, or whether, a fully remote Adderall prescription works in 2027. Three outcomes are possible: the permanent rule is finalized, the DEA issues another temporary extension as it has done four times already, or the flexibilities lapse and prescribing reverts to the Ryan Haight Act’s in-person requirement. We will update this page when the DEA acts, and the verification date in the box above reflects our most recent regulatory review.
How a legitimate online Adderall prescription actually happens
A legitimate telehealth ADHD service runs a diagnostic evaluation, not a dispensing process. You complete intake forms and often standardized screening instruments, then meet a licensed clinician over video for an assessment that typically reviews your symptoms, history, prior records if available, and other possible explanations for your concerns. The prescription decision belongs entirely to the clinician’s judgment. A stimulant prescription is one possible outcome of that evaluation – not its purpose – and providers can and do decline to prescribe when the clinical picture does not support it. A declined prescription from a careful clinician is the system working as intended.
If a stimulant is prescribed, expect some friction that no platform fully controls. Recurring stimulant shortages have disrupted fills in recent years, so a valid prescription does not mean your pharmacy has stock on the day you need it. Controlled prescriptions also cannot always be e-sent to every pharmacy; Circle Medical patients, for example, have reported transmission friction with CVS specifically. And because Schedule II medications cannot be refilled the way ordinary prescriptions are, continuing treatment requires ongoing follow-up visits – reputable platforms build that cadence in rather than treating it as optional.
Red flags: the Done case and what it teaches
In November 2025, a federal jury convicted the founder/CEO and the clinical president of Done, a digital ADHD company, in a case involving roughly $100 million in Adderall distribution and healthcare fraud. According to the Department of Justice, the conduct included advertising deliberately targeted at drug seekers, compensation structures that pressured clinicians to refill prescriptions, and auto-refills issued without patient visits. Notably, donefirst.com still operates as of June 2026 – a criminal conviction of executives does not automatically take a website offline, which is exactly why patients need to evaluate platforms themselves.
The case maps directly onto the warning signs worth watching for: a platform that promises or strongly implies you will receive a prescription, a platform that refills controlled medications without requiring visits, and marketing that treats medication as a product you order rather than a treatment a clinician may or may not recommend. Every legitimate service on our roster frames the evaluation, not the prescription, as what you are paying for.
If stimulants aren’t the right fit
Stimulants are not the only evidence-based ADHD medication, and for some people they are not the best one. Atomoxetine and other non-stimulant medications are legitimate first-line options for certain patients – and because they are not controlled substances, none of the regulatory uncertainty on this page applies to them. Any telepsychiatry service can prescribe them, in any state, with no special DEA telehealth rules involved. That is the lane Talkspace operates in deliberately: it prescribes no controlled substances, which makes it a reasonable choice if you and your clinician land on a non-stimulant plan, and the wrong choice if a stimulant turns out to be clinically appropriate.
Frequently asked questions
Can online doctors prescribe Adderall in 2026?
Yes. As of June 2026, DEA-registered telehealth providers can prescribe Adderall and other Schedule II stimulants without a prior in-person visit, under temporary federal flexibilities that run through December 31, 2026. Whether a specific platform will prescribe to you also depends on your state’s law, the platform’s own policy, and most importantly the prescribing clinician’s judgment after a real evaluation.
Will this still be legal in 2027?
Unknown as of June 2026. The current federal flexibilities expire December 31, 2026. The DEA proposed a permanent “Special Registrations for Telemedicine” rule in January 2025 but has not finalized it, though it has said it intends to do so before the deadline. The permanent rule contemplates added requirements such as PDMP checks, audio-video mandates, and possible in-person requirements for Schedule II drugs. We will update this guide when the DEA finalizes the rule or issues another extension.
Which states restrict online Adderall prescriptions?
The federal rule applies nationwide, but states can be stricter. New Jersey requires an in-person follow-up every three months for Schedule II medications, while Florida amended its statute (section 456.47) in 2022 to explicitly permit Schedule II teleprescribing for psychiatric disorders. Platform policies add another layer: Circle Medical, for example, excludes controlled substances for residents of Georgia, Ohio, Michigan, and North Carolina. Check your state’s law and the platform’s state list before booking.
Can a platform guarantee a prescription?
No, and any platform that suggests otherwise is showing you a red flag. A prescription is a clinical decision made by a licensed provider after an evaluation, and providers regularly decline when the assessment does not support stimulant treatment. The November 2025 federal convictions of Done’s executives involved exactly this pattern – marketing aimed at drug seekers and refills issued without visits. Treat “guaranteed” medication marketing as a reason to leave, not a feature.
Can online psychiatrists prescribe Vyvanse and other stimulants?
Yes. The temporary federal flexibilities in effect as of June 2026 cover Schedule II through Schedule V controlled substances, which includes Vyvanse, Adderall, and other ADHD stimulants. The same three-layer caveat applies: state law and platform policy can each narrow what a given service will prescribe, and the clinician’s evaluation determines whether any stimulant is appropriate for you.
What if I can’t or don’t want a stimulant?
Non-stimulant ADHD medications such as atomoxetine are evidence-based options for some patients, and because they are not controlled substances, any telepsychiatry service can prescribe them in any state without DEA telehealth restrictions. If you expect to pursue a non-stimulant plan, a service like Talkspace, which prescribes non-stimulants only, may fit; if you want all medication options on the table, choose a platform that can prescribe controlled substances in your state.
The rules above are the floor; the right platform for you depends on your state, your insurance, and what a clinician actually recommends after an evaluation. We have compared each service’s published prescribing policies, state coverage, pricing, and regulatory record so you can weigh them on the same terms – compare ADHD telehealth providers side by side to see which ones can legitimately treat ADHD where you live.
Related ADHD guides
- ADHD telehealth that takes insurance – plan-by-plan, including Medicaid and TRICARE
- How to get ADHD medication online – legally – the process, costs, and red flags
- The Done ADHD collapse – what happened, and safer alternatives
- State rules: Florida · California · Georgia · Texas
Health Disclaimer: BestMedsHub is not a healthcare provider, telehealth service, pharmacy, or medical organization. We do not prescribe medication, diagnose conditions, render medical opinions, or facilitate clinical consultations. All content is for general informational and comparison purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified physician, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any treatment, medication, supplement, or health program. Never disregard professional medical advice or delay seeking it because of anything you have read on this site. If you think you may have a medical emergency, call your local emergency number immediately.
FDA & Prescription Medication Disclaimer: Prescription medications referenced on this page are available only through a licensed healthcare provider after a clinical evaluation, and may not be appropriate or safe for everyone. Any statements regarding dietary supplements, wellness products, or off-label uses have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary and are not guaranteed. Always read the medication guide and consult your prescriber and pharmacist about side effects, contraindications, and drug interactions.
